Study: Bulengo-Ransby 1993, New England Journal of Medicine
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients
Citation
Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ et al (1993). New England Journal of Medicine. PubMed id 8479462.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Dark marks after acne (post-inflammatory hyperpigmentation) Tier A thin
A 54 Black adults with post-inflammatory hyperpigmentation who completed the study (n=54)
Randomised, double-blind, vehicle-controlled, 40 weeks; tretinoin 0.1% cream (a prescription medicine) on face or arms against vehicle cream.
Facial lesions in the tretinoin group were significantly lighter than vehicle (P<0.001). Colorimetry showed 40% lightening of lesions against 18% with vehicle (P=0.05). Improvement began after about 4 weeks. Retinoid dermatitis developed in 12 of 24 tretinoin-treated people (50%) but eased with time. Tretinoin lightened normal skin slightly.
As recorded in this card: Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ et al (1993), New England Journal of Medicine, [primary]
Note: 1993; relatively small; prescription in the UK. Mentioned as evidence that a class of treatment (prescription retinoids) has been tested in Black people, not as a dose.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.